Press Releases

Omeza Receives FDA Clearance for Omeza® Collagen Matrix

Omeza announced today the U.S. Food and Drug Administration (FDA) cleared Omeza® Collagen Matrix through the FDA 510(k) premarket notification process. Omeza® Collagen Matrix is Omeza’s first Rx product, and the first drug/device combination matrix of its kind for chronic wound care.

Omeza Closes on $5MM Bridge Financing

COMPANY IS HEADING TOWARD A $20MM SERIES “A” RAISE Sarasota, Florida 05/010/2021 — Omeza, LLC announced today that it has closed on the sale of $5,000,000 of convertible notes to 22 current …

Read More →

OMEZA Launches second otc Product

Sarasota, FL – 11 09 2020 – Omeza is launching Omeza® Lidocaine Oil, an over the counter (OTC) external analgesic. The product is indicated for temporary relief from pain and itching from …

Read More →

Omeza Hires Director of Research and Development

Dr. Venus Dookwah-Roberts joined Omeza as Director of Research and Development.  Her responsibilities are planning, organizing, coordinating, and overseeing all activities related to extension of the current Omeza product platform, including creation of new products, integration of new raw materials, and all related testing and analytics.  She oversees the internal R&D testing and laboratory and manages the pipeline created by the Chief Innovations Officer.